Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-12 Purchase | 2022-04-12 4:05 pm | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 10,000 | $8.4 | $84,000 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Tax Withholding | 2024-02-15 6:18 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 6,560 | $7.9 | 210,741 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:08 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 568,900 | $0 | 682,801 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 7:24 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 489,600 | $0 | 489,600 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-31 4:13 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 7,500 | $0 | 168,901 (Direct) | View |
| 2023-08-30 Tax Withholding | 2023-08-31 4:13 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 2,205 | $2.93 | 168,901 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:30 pm | N/A 2033-05-31 | Editas Medicine Inc. | EDIT | Hirsch Andrew Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-15 4:44 pm | N/A 2033-02-14 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 448,800 | $0 | 475,806 (Direct) | View |
| 2023-01-30 Tax Withholding | 2023-02-01 4:09 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 4,319 | $7.78 | 89,506 (Direct) | View |
| 2023-01-30 Exercise | 2023-02-01 4:09 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 12,500 | $0 | 89,506 (Direct) | View |
| 2022-05-26 Tax Withholding(A) | 2022-06-14 4:45 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 3,675 | $7.01 | 18,825 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:30 pm | N/A 2032-06-08 | Editas Medicine Inc. | EDIT | Hirsch Andrew Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 4:15 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 12,500 | $0 | 97,500 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-23 4:30 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 87,500 | $0 | 87,500 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-07 4:11 pm | N/A 2031-06-02 | Editas Medicine Inc. | EDIT | Hirsch Andrew Director | 11,538 | $0 | 11,538 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 9:00 pm | N/A 2030-09-30 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew See Remarks | 1,691,672 | $0 | 1,691,672 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 4:18 pm | N/A 2030-06-09 | Editas Medicine Inc. | EDIT | Hirsch Andrew Director | 11,538 | $0 | 11,538 (Direct) | View |
| 2020-04-22 Tax Withholding | 2020-04-24 4:06 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Hirsch Andrew Chief Financial Officer | 1,927 | $45.91 | 36,057 (Direct) | View |
| 2020-04-22 Exercise | 2020-04-24 4:06 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Hirsch Andrew Chief Financial Officer | 5,893 | $0 | 36,057 (Direct) | View |
| 2020-04-14 Tax Withholding | 2020-04-15 4:26 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Hirsch Andrew Chief Financial Officer | 1,599 | $40.64 | 31,081 (Direct) | View |
| 2020-04-13 Exercise | 2020-04-15 4:26 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Hirsch Andrew Chief Financial Officer | 5,387 | $0 | 31,081 (Direct) | View |
| 2020-02-22 Exercise | 2020-02-25 4:27 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Hirsch Andrew Chief Financial Officer | 3,333 | $0 | 23,185 (Direct) | View |
| 2020-02-24 Tax Withholding | 2020-02-25 4:27 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Hirsch Andrew Chief Financial Officer | 1,056 | $48.66 | 23,185 (Direct) | View |
| 2020-02-18 Tax Withholding | 2020-02-19 4:51 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Hirsch Andrew Chief Financial Officer | 886 | $52.01 | 73,991 (Direct) | View |
| 2020-02-16 Exercise | 2020-02-19 4:51 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Hirsch Andrew Chief Financial Officer | 2,750 | $0 | 73,991 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:51 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Hirsch Andrew Chief Financial Officer | 57,000 | $0 | 73,991 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 4:31 pm | N/A 2029-06-11 | Editas Medicine Inc. | EDIT | Hirsch Andrew Director | 11,538 | $0 | 11,538 (Direct) | View |
| 2019-04-22 Option Award | 2019-04-24 5:38 pm | N/A N/A | AGIOS PHARMACEUTICALS INC | AGIO | Hirsch Andrew Chief Financial Officer | 17,678 | $0 | 17,678 (Direct) | View |